ozagrel and Vascular-Diseases

ozagrel has been researched along with Vascular-Diseases* in 2 studies

Other Studies

2 other study(ies) available for ozagrel and Vascular-Diseases

ArticleYear
Endothelium dysfunction in hind limb arteries of male Zucker Diabetic-Sprague Dawley rats.
    Biochemical pharmacology, 2022, Volume: 206

    Endothelium dysfunction produces peripheral vascular disease comorbidities in type 2 diabetes, including hypertension, and critical limb ischemia. In this study we aimed to test endothelial dysfunction, the vasodilator effects of a proteinase-activated receptor 2 (PAR2) agonist (2fLIGRLO), and thromboxane A

    Topics: Acetylcholine; Animals; Arteries; Diabetes Mellitus, Type 2; Endothelium, Vascular; Male; Mesenteric Arteries; Nitroprusside; Placenta Growth Factor; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptor, PAR-2; Vascular Diseases; Vasodilation

2022
Application of prostacyclin analogue and thromboxane synthetase inhibitor to chronic vascular rejection after kidney transplantation.
    Transplantation proceedings, 1987, Volume: 19, Issue:5

    Topics: Acrylates; Chronic Disease; Epoprostenol; Graft Rejection; Humans; Kidney Transplantation; Methacrylates; Thromboxane-A Synthase; Ticlopidine; Time Factors; Vascular Diseases

1987